We also take advantage of the availability of LCLs from ALS patients carrying mutations in SOD1, TARDBP and FUS genes to investigate whether and how mutations affect different ALS-linked pathways. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.